Any understanding readers may have taken from the article that Dr. Moses was performing cardiovascular surgery while under the influence of cocaine was not intended.

FORBES: New York Post Disavows Portions Of Article About Jeffrey Moses

According to an AHA online survey, the top two reasons women defer heart surgery is "caring for others, " and "family responsibilities, " said Dr. Rakesh Suri, a consultant in the division of cardiovascular surgery at the Mayo Clinic.

MSN: Heart disease can be serious, silent in young women

An analysis of 10 studies involving a total of 393 patients, published earlier this year in the Journal of Thoracic and Cardiovascular Surgery, found between 26% and 83% of patients getting the new surgery were able to stop taking proton-pump inhibitors.

WSJ: New Surgical Option for Heartburn

In the trial, patients who received Taxus instead of Cypher were 80% more likely have a serious cardiovascular event or surgery.

FORBES: J&J's Eleventh-Hour Victory

Dr. Robert Michler, chairman of Cardiovascular and Thoracic Surgery at Montefiore-Einstein Heart Center, said the data should act as a "wake-up call" for physicians, surgeons and patients.

CNN: STORY HIGHLIGHTS

Some prostate-cancer treatments-- such as surgery-- may also be responsible for the uptick in cardiovascular deaths, the researchers note.

CNN: STORY HIGHLIGHTS

Furthermore, 27 percent of the surgery group but only 13 percent of the monitoring group developed a cardiovascular problem such as a heart attack, heart disease or stroke.

WSJ: Study questions kidney cancer treatment in elderly

The upside to its story, he says, comes as the company transitions from the current cosmetic-and-reconstructive surgery approach to regenerative medicine specifically in the area of both acute and chronic cardiovascular disease.

FORBES: Human Body's Fat Seen As best Source of Stem Cells For Regenerative Therapies

Since only 300, 000 patients undergo surgery every year for prostate enlargement, compared with some 60 million who suffer from cardiovascular disease, Rabiner opted to pursue that market in 2000.

FORBES: OmniSonics' Clot Buster